Cynata (ASX:CYP) receives UK approval for clinical trial of Limb Ischaemia treatment
14 Jan 2020 - Cell therapeutics company Cyanata (ASX:CYP) has received the greenlight from British medical authority MHRA to begin the company’s Phase 2 clinical trial of its CYP-002 product.